Mouse double minute 2 (Mdm2) is a multifaceted oncoprotein that is highly regulated with distinct domains capable of cellular transformation. Loss of Mdm2 is embryonically lethal, making it difficult to study in a mouse model without additional genetic alterations. Global overexpression through increased Mdm2 gene copy number (Mdm2 Tg ) results in the development of hematopoietic neoplasms and sarcomas in adult animals. In these mice, we found an increase in osteoblastogenesis, differentiation, and a high bone mass (HBM) phenotype.
Introduction
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Bone is a complex and dynamic organ, simultaneously regulating hematopoiesis while continuously adapting to physiological conditions for optimal strength, support, and movement. The bone remodeling process encompassing bone resorption and apposition reveals an intricate equilibrium regulated by osteoblasts (OBs) and osteoclasts (OCs). Imbalances of remodeling can perturb bone microstructures and initiate pathologies such as bone loss, periodontal disease, arthritis, and malignancy.
The glycoprotein osteonectin is an important marker of OB differentiation, inducing mineralization in normal skeletal tissue [Doi et al., 1989; Romberg et al., 1985; Romberg et al., 1986; Termine et al., 1981a; Termine et al., 1981b] ; [Jundt et al., 1987; Termine et al., 1981b] . Consequently, osteonectin-null mice exhibit reduced OB and OC numbers with approximately 50% decrease in bone formation rate [Delany et al., 2000; Doi et al., 1989] . The osteonectin gene is regulated by numerous transcription factors including Sp1 in OBs [Chamboredon et al., 2003] . Sp1 is a zinc finger transcription factor that binds to GC rich motifs and cooperates with other transcription factors to induce gene expression [Mann et al., 2001] . Converse to SP1, the transcription factor and tumor suppressor p53 is an important regulator of OBs and OCs. Loss of p53 (-/-) in OB precursors results in OB proliferation and OC differentiation, elevated levels of RUNX2, and generation of a high bone mass (HBM) phenotype [Liu and Li, 2010] ; [Wang et al., 2006] . These mice also develop of osteosarcoma as they age [Walkley et al., 2008] . Furthermore, osteosarcoma cells with p53 deletion also exhibit high 4 levels of RUNX2 and enhanced osteogenesis compared to those with wild type p53 [He et al., 2015] .
Mdm2, a negative regulator of p53, has also been implicated in the development of osteosarcoma with gene amplification found in a third of highgrade dedifferentiated osteosarcomas and the late stages of metastasis [Chen et al., 2012] ; [Guerin et al., 2016] ; [Yoshida et al., 2012] ; [Salinas-Souza et al., 2013] .
While the oncogenic function of Mdm2 is correlated with neoplastic development, little is known about the proto-oncogene role in maturing animals [Haines, 1997; Zhao et al., 2014] . Examination of Mdm2 expression patterns during embryogenesis shows ubiquitous expression during 7.5-11.5 days post coitum (dpc), and in the teeth at 14-18 dpc independent of p53 expression [Leveillard et al., 1998 ]. Deletion of Mdm2 in mice (Mdm2 -/-) is embryonically lethal due to p53-induced cell growth arrest or apoptosis, whereas Mdm2 -/-; p53 -/-mice remain viable [Jones et al., 1995; Montes de Oca Luna et al., 1995] ; [Maluszek, 2015; Manfredi, 2010] . Deletion of Mdm2 only in OB progenitor cells results in numerous skeletal defects and reduced mineralization leading to neonatal death [Lengner et al., 2006] , suggesting that Mdm2 has both p53-dependent and independent roles.
The influence of Mdm2 upregulation in the rich cellular milieu remains largely unknown due to the inherent difficulties in investigating the function of Mdm2 in adult animals as p53 -/-; Mdm2 -/-animals develop hematopoietic malignancies and sarcomas early [Abbas et al., 2010; Chen et al., 2012; Das et 5 al., 2012; Lengner et al., 2006] ; [Jones et al., 1998; Pant et al., 2012 ]. Here we demonstrate that Mdm2 overexpression specific to osteoblast lineage cells leads to a high bone mass phenotype and corrects age-related bone loss in female mice.
Materials and Methods
Global overexpressing Mdm2 (Mdm2 Tg ) C57BL/6 mice. For these studies 3-month-old male WT and globally overexpressing Mdm2 Tg C57BL/6 mice were a generous gift from Stephen Jones [Jones et al., 1998 ]. Overexpression of Mdm2 was analyzed by western blot analysis.
Mdm2
ObTg C57BL/6 and DBA mice. For these studies, female and male WT and Mdm2 ObTg (on a C57BL/6 or DBA background) were utilized. DBA mice were obtained in-house. There were no significant differences between male and female mice. C57BL/6 mice were obtained from Jackson Laboratories. All procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of the Indiana University School of Medicine, and complied with NIH guidelines, and the Guide for the Care and Use of Laboratory Animals. To generate Mdm2 ObTg mice, the osteoblast and osteocyte specific promoter, collagen 1.7 (Col1.7) was ligated upstream of the Mdm2 cDNA and injected into embryos. Overexpression of Mdm2 was monitored by western blot analysis.
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BMD and μCT analysis of bone. Whole body and femoral BMD (g/cm 2 ) was measured in vivo by peripheral DEXA (PIXImus, GE Lunar Madison, WI).
Trabecular bone parameters of the distal femur designated for histology were quantified by μCT (Skycan 1172) as previously described [Feher et al., 2010; Warden et al., 2008] ; [Meijome et al., 2015; Weatherholt et al., 2013] . Images were binarized to calculate three-dimensional BV parameters: trabecular bone volume fraction (BV/TV, %), trabecular number (Tb.N, 1/mm), trabecular thickness (Tb.Th, mm), and trabecular separation (Tb.Sp, mm).
Histology/histomorphometry. WT and Mdm2 ObTg mice were administered 30mg/kg fluorochrome calcein (IP) 13 and 3 days prior to sacrifice to label actively forming bone surfaces. Static and dynamic histomorphometric analysis of trabecular bone was performed on femurs as previously described [Feher et al., 2010; Meijome et al., 2015; Warden et al., 2008] . Histological measurements were made with a semiautomatic analysis system (Bioquant OSTEO 7.20.10, Bioquant Image Analysis Co.) attached to a microscope with an ultraviolet light source (Nikon Optiphot 2 microscope, Nikon). Measurements were done on one stained (static) and one unstained (dynamic) section for each animal.
Preparation of neonatal calvarial cells (OB).
Neonatal murine calvarial OB cells were prepared as previously described from WT and Mdm2 ObTg C57BL/6 and DBA mice [Horowitz et al., 1994] . Our technique is a modified version of the basic method described by Wong and Cohn [Wong and Cohn, 1975] . Dissected 7 calvaria from neonatal mice were treated with EDTA in PBS for 30 min and digested with collagenase (200U/mL) at 37°C. [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] and 50-65 min) were used as the OB starting population and seeded at 2 x10 4 cells/ml (optimal pre-tested). This population contains ~90% OB/OB precursors as previously established [Horowitz et al., 1994] , [Simmons et al., 1982] , [Jilka and Cohn, 1981] . OB cultures were fed twice per week with αMEM supplemented with 10% FBS, ascorbic acid (AA; 50 µg/ml added on day 0 and at all feedings), and β-glycerophosphate (BGP; 5mM added starting on day 7 and all subsequent feedings).
In Vitro OC-like cell formation models. OC-like cells were generated as previously described [Kacena et al., 2004] . In brief, 2x10 6 control or Mdm2 TgOb BM cells/ml and 20,000 primary calvarial OB/ml were grown in a α-MEM supplemented with 10% FCS and 10 -8 M 1,25(OH)2D3. The media was changed every other day for 6-8 days for OC formation then fixed with 2.5% gluteraldehyde in PBS for 30 min at RT. TRAP positive multinucleated cells (>3 nuclei) were quantified.
Cell culture. Human MG63 osteosarcoma cells were maintained in 10% FBS DMEM, and treated with ascorbic acid (AA; 1ul/ml) and ß-glycerolphosphate (BGP; 10ul/ml) to induce differentiation.
Protein analysis. Cell monolayers were harvested by scraping with in ice-cold 1X PBS. After centrifugation PBS was removed, pelleted cells were lysed with urea lysis buffer on ice for >2 hr and debris centrifuged. Supernatant was collected and protein concentrations were determined by BioRad assay. Protein was fractionated by SDS/PAGE and transferred to PVDF membrane (Amersham Biosciences). Membranes were blocked for 1 hr at room temperature (RT) in 5% non-fat dry milk in PBST, and subsequently incubated with primary antibodies in milk (1:1000) for 2 hr at RT. Mdm2 (SMP14, 2A10, and 4B11), Osteonectin (AON-1), and GAPDH (6C5) were purchased from Millipore (Calbiochem, Billerica, MA). β-actin (C4) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Cell cycle analysis. WT and Mdm2
ObTg OB were assessed on days 1, 3, 5, and 7 of culture. Cells were stained with equal volumes of staining buffered (0.1mg/ml propidium iodide + 0.6% Nonidet P40 in PBS) and 2mg/ml RNase as described previously [Srour et al., 1992] . OB were mixed well and incubated on ice for 30 min. A FACS caliber flow cytometer (BDIS) was used to determine the percentage of cells in phase G0/G1 and S/G2+M.
Quantitative analysis of calcium deposition by alizarin red staining. To evaluate calcium deposition, monolayers of neonatal calvarial OB were stained with Alizarin Red S after 14 days in culture as previously described [Stanford et al., 1995] . Briefly, monolayers were washed 2X with PBS, subsequently fixed in 9 ice cold 70% (v/v) ethanol for 1 hr, and washed 2X with water. Monolayers were stained with 40mM Alizarin Red S (pH 4.2) for 10 min at RT while shaking.
Unbound dye was washed off with 5X water and 1X with PBS for 15 min at RT with shaking.
Statistical analysis. Data are presented as the Mean ±1 SEM unless otherwise stated. Experiments were performed as duplicates or triplicates at least 3X. The sample size for in vivo studies is presented in the corresponding figure legends.
Student's t-test was performed when only two groups were compared. For ease of reporting and to increase sample size, data from both genders which shared identical properties were combined for all the in vivo data analysis. One-way analyses of variances (one-way ANOVA) with LSD were used to make multiple group comparisons. Two-way analyses of variances (two-way ANOVA) were used to determine significant main effect contribution in cell co-culture groups, with BM genotype and OB genotype being the independent variables, as well as significant interaction effect between these independent variables. Statistical Package for Social Sciences (IBM SPSS 19; SPSS Inc., Armonk, NY) software was used to analyze the data with two tailed with a level of significance at 0.05.
Results
Previous efforts to understand Mdm2 function on oncogenic transformation through generation of global overexpressing transgenic mice (Mdm2 Tg ) led to lymphoma and sarcoma phenotypes in adult mice [Jones et al., 1998 ]. While this limited the utility of the model for studying physiological roles of Mdm2 in aged animals, the effects of global Mdm2 over-expression on osteogenesis, bone volume and architecture could be examined prior to 4 months of age. Micro-computed tomographic (μCT) analysis of 3-month-old male Mdm2 Tg mice revealed an increase in trabecular bone fraction (BV/TV; Figure 1a ,and c ) and improved architecture in the vertebrae (Figure d-f) .
Additionally, the material bone mineral density (mBMD) of Mdm2 Tg mice were significantly greater than in wild-type (WT) (Figure 1b) . Overexpression of Mdm2 also significantly enhanced ex vivo OB differentiation from BM stromal cells (BMSCs) represented by mineralized nodules and increased alkaline phosphatase positive colonies compared to WT (Figure 1g, h ).
Though not definitive, these findings from the global Mdm2 Tg strongly suggested a direct role of Mdm2 in differentiation and function. To definitively determine this skeletal phenotype was due to a direct role of Mdm2 in OBs, rather than indirect role via its effects in other cells in the BM microenvironment, we generated mice that overexpress Mdm2 only in cells of the osteogenic lineage (Mdm2 TgOb ) using a construct that contained the collagen 1.7kb fragment of the Col1a1 promoter (Col1.7) upstream of the murine Mdm2 cDNA. This promoter activity is limited to maturing OBs, and osteocytes. Two founder lines were generated that contained the Mdm2 transgene (Mdm2 TgOb ) as detected by 11 PCR. To confirm that this promoter was active during OB differentiation, BMSCs were isolated from long bones and vertebrae. These cells were treated with ascorbic acid and β-glycerophosphate to induce osteoblastogenesis. Western blot analysis showed that Mdm2 levels were higher in BMSCs isolated from Mdm2 TgOb long bone and vertebrae compared to controls (Figure 2a ).
Histological analysis of Mdm2 distal femur demonstrated Mdm2 staining in OBs
and not OCs (Figure 2b) . Mdm2 TgOb OB cell proliferation was also higher than controls ( Figure 2c ). This result is consistent with the increase in calvarial OB proliferation observed in OB generated from p53 -/-; Rb -/-mice as compared to WT counterparts. Lysates from Mdm2 TgOb calvaria OBs show marked reductions in p53 levels compared to control OBs. Interestingly, p53 -/-mice have a significant increase in BMD, BFR, and OB number [Wang et al., 2006] . Additionally, Next, to more directly compare our findings with that observed in the global Mdm2 Tg mice, we examined the vertebrae of Mdm2 TgOb mice. In Figure   6a -e, vertebrae from Mdm2 TgOb mice, like Mdm2 Tg mice, have significant increases in BV/TV and trabecular number, with decreases in trabecular separation. Analysis of both the vertebral and whole body BMD in Mdm2 TgOb mice was also significantly elevated compared to controls. The vertebral data is from 9-month-old female mice, an age when control mice already begin to lose bone mass. Interestingly, in the 9-month-old Mdm2 TgOb mice the age-related osteoporosis was corrected compared to littermate controls of the same age (Figure 6a ).
Discussion
While the globally Mdm2 overexpressing transgenic animals developed tumors arising from soft tissue or hematopoietic system, we followed the 14 Mdm2 TgOb animals for over a year and there was no evidence of neoplastic development. The major difference between the global Mdm2 Tg and osteoblastspecific Mdm2 TgOb is sustained expression versus acute expression. The acute expression of Mdm2 TgOb may be necessary for the generation of high quality bone as observed in our study versus sustained expression, which leads to neoplastic development.
Many studies have been conducted on mdm2 -/-and conditional knockout animals; however, these studies are limited as a lethal phenotype is evident early during development due to p53. Knockout of p53 and Mdm2 lead to developmental defects or neoplastic development. Counter to using a knockout approach, Mdm2 Tg animal, we were able to gain insight into physiological activity of Mdm2 in the presence of p53 in older animals. OB differentiation is guided by several extracellular signaling factors including fibroblast growth factors, parathyroid hormone, estrogen, bone morphogenetic protein, transforming growth factor β, Wnt, and members of the growth hormone/IGF family [Erlebacher et al., 1998; Hu et al., 2005; Isogai et al., 1996; Marie, 2003; Okazaki et al., 2002; Yamaguchi et al., 2000; Zheng et al., 1992] . All or most of these factors can have an influence on Mdm2 gene expression or protein levels and activity [Araki et al., 2010; Heron-Milhavet and LeRoith, 2002; Shaulian et al., 1997; Yang et al., 2006] .
Our data shows a high bone mass phenotype (Fig.1) . The increase in bone mass and bone mass turnover of these animals guided us to investigate what induces this phenotype downstream. We show that increased Mdm2 is 15 associated with increased osteonectin, a factor important for mineralization. This was evident in our animal model and more importantly, in human cells in vitro (Fig 3) . Upon examination of the transcription factor implicated in the induction of osteonectin, Sp1, we found it was elevated in human and murine models (Fig 3) .
The link to Mdm2 is important as osteonectin knockout animals present with severe skeletal defects [Boskey et al., 2003; Delany et al., 2000] . Thus, the biometric and molecular data support a novel physiological role for Mdm2 in the regulation of the bone microenvironment.
Collectively, our data suggest that Mdm2 has a significant proto-oncogene function in bone formation. Thus, diminished levels of Mdm2 may be involved in human bone pathologies. Moreover, targeting Mdm2 for acute expression may be an effective method to alleviate age-associated osteoporosis. TgOb compared to wild type littermate controls upon induction of OB differentiation. Bone marrow cells were isolated from both the long bones (LB) and vertebrae (V) of 6-week-old female littermates. Mdm2 expression is higher in bone marrow cultures derived from Tg females as compared to cultures derived from WT control females. B. Mdm2 staining in OBs (red arrow) and not in OCs (black arrow) C. An increase in osteoblast proliferation from calvarial OB isolated from Mdm2
TgOb is observed compared to wild type littermate control mice. D. An increase in osteocalcin mRNA in Mdm2
TgOb mice compare to WT controls. Asterisk signifies statistical significance at p<0.05. TgOb mice compared to wild type littermate controls. Data in all figures is presented as the average ± SEM. Asterisk signifies statistical significance at p<0.05.
